Barclays Maintains an 'Equalweight' on Forest Laboratories (FRX); Outlook/Thesis Unchanged Despite Beat
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Forest Laboratories (NYSE: FRX), PT increased by $1 to $38.
Barclays analyst says, "Outlook ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Outlook ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


